Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 187 entries
Sorted by: Best Match Show Resources per page
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288.

Annals of oncology : official journal of the European Society for Medical Oncology

Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A.
PMID: 32089397
Ann Oncol. 2020 Apr;31(4):552. doi: 10.1016/j.annonc.2020.02.001. Epub 2020 Feb 20.

No abstract available.

Cite
Bjelic-Radisic V, Cardoso F, Cameron D, et al. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Ann Oncol. 2020;31(4):552doi: 10.1016/j.annonc.2020.02.001.
Bjelic-Radisic, V., Cardoso, F., Cameron, D., Brain, E., Kuljanic, K., da Costa, R. A., Conroy, T., Inwald, E. C., Serpentini, S., Pinto, M., Weis, J., Morag, O., Lindviksmoen Astrup, G., Tomaszewski, K. A., Pogoda, K., Sinai, P., Sprangers, M., Aaronson, N., Velikova, G., Greimel, E., Arraras, J., Bottomley, A. (2020). Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Annals of oncology : official journal of the European Society for Medical Oncology, 31(4), 552. https://doi.org/10.1016/j.annonc.2020.02.001
Bjelic-Radisic, V, et al. "Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288." Annals of oncology : official journal of the European Society for Medical Oncology vol. 31,4 (2020): 552. doi: https://doi.org/10.1016/j.annonc.2020.02.001
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Ann Oncol. 2020 Apr;31(4):552. doi: 10.1016/j.annonc.2020.02.001. Epub 2020 Feb 20. PMID: 32089397.
Copy Download .nbib Format: NLM
Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Gasoyan H, Soans RS, Ibrahim JK, Aaronson WE, Sarwer DB.
PMID: 34753674
Surg Obes Relat Dis. 2021 Oct 15; doi: 10.1016/j.soard.2021.10.007. Epub 2021 Oct 15.

BACKGROUND: Insurance-mandated precertification requirements are barriers to bariatric surgery. The value of their prescription, based on insurance type rather that the clinical necessity, is unclear.OBJECTIVES: To determine whether there is an association between insurance-mandated precertification criteria for bariatric surgery...

Cite
Gasoyan H, Soans RS, Ibrahim JK, et al. Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery. Surg Obes Relat Dis. 2021;doi: 10.1016/j.soard.2021.10.007.
Gasoyan, H., Soans, R. S., Ibrahim, J. K., Aaronson, W. E., & Sarwer, D. B. (2021). Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, . https://doi.org/10.1016/j.soard.2021.10.007
Gasoyan, Hamlet, et al. "Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery." Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. (2021). doi: https://doi.org/10.1016/j.soard.2021.10.007
Gasoyan H, Soans RS, Ibrahim JK, Aaronson WE, Sarwer DB. Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery. Surg Obes Relat Dis. 2021 Oct 15; doi: 10.1016/j.soard.2021.10.007. Epub 2021 Oct 15. PMID: 34753674.
Copy Download .nbib Format: NLM
Right-sided heart failure: diagnosis and treatment strategies.

Current treatment options in cardiovascular medicine

Matthews JC, Dardas TF, Dorsch MP, Aaronson KD.
PMID: 18647588
Curr Treat Options Cardiovasc Med. 2008 Aug;10(4):329-41. doi: 10.1007/s11936-008-0053-6.

Right ventricular (RV) dysfunction in the setting of cardiomyopathy, ischemia, and pulmonary hypertension is associated with high morbidity and mortality, but therapeutic clinical trials examining RV failure as a primary outcome are lacking. This review focuses on the ontologic,...

Cite
Matthews JC, Dardas TF, Dorsch MP, et al. Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med. 2008;10(4):329-41doi: 10.1007/s11936-008-0053-6.
Matthews, J. C., Dardas, T. F., Dorsch, M. P., & Aaronson, K. D. (2008). Right-sided heart failure: diagnosis and treatment strategies. Current treatment options in cardiovascular medicine, 10(4), 329-41. https://doi.org/10.1007/s11936-008-0053-6
Matthews, Jennifer Cowger, et al. "Right-sided heart failure: diagnosis and treatment strategies." Current treatment options in cardiovascular medicine vol. 10,4 (2008): 329-41. doi: https://doi.org/10.1007/s11936-008-0053-6
Matthews JC, Dardas TF, Dorsch MP, Aaronson KD. Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med. 2008 Aug;10(4):329-41. doi: 10.1007/s11936-008-0053-6. PMID: 18647588.
Copy Download .nbib Format: NLM
Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery.

Frontiers in surgery

Aaronson DM, Martinez Del Campo E, Boerger TF, Conway B, Cornell S, Tate M, Mueller WM, Chang EF, Krucoff MO.
PMID: 34660677
Front Surg. 2021 Oct 01;8:730367. doi: 10.3389/fsurg.2021.730367. eCollection 2021.

Direct electrical stimulation of the brain is the gold standard technique used to define functional-anatomical relationships during neurosurgical procedures. Areas that respond to stimulation are considered "critical nodes" of circuits that must remain intact for the subject to maintain...

Cite
Aaronson DM, Martinez Del Campo E, Boerger TF, et al. Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery. Front Surg. 2021;8:730367doi: 10.3389/fsurg.2021.730367.
Aaronson, D. M., Martinez Del Campo, E., Boerger, T. F., Conway, B., Cornell, S., Tate, M., Mueller, W. M., Chang, E. F., & Krucoff, M. O. (2021). Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery. Frontiers in surgery, 8730367. https://doi.org/10.3389/fsurg.2021.730367
Aaronson, Daniel M, et al. "Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery." Frontiers in surgery vol. 8 (2021): 730367. doi: https://doi.org/10.3389/fsurg.2021.730367
Aaronson DM, Martinez Del Campo E, Boerger TF, Conway B, Cornell S, Tate M, Mueller WM, Chang EF, Krucoff MO. Understanding Variable Motor Responses to Direct Electrical Stimulation of the Human Motor Cortex During Brain Surgery. Front Surg. 2021 Oct 01;8:730367. doi: 10.3389/fsurg.2021.730367. eCollection 2021. PMID: 34660677; PMCID: PMC8517489.
Copy Download .nbib Format: NLM
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling.

Cancer discovery

Adamopoulos C, Ahmed TA, Tucker MR, Ung PMU, Xiao M, Karoulia Z, Amabile A, Wu X, Aaronson SA, Ang C, Rebecca VW, Brown BD, Schlessinger A, Herlyn M, Wang Q, Shaw DE, Poulikakos PI.
PMID: 33568355
Cancer Discov. 2021 Jul;11(7):1716-1735. doi: 10.1158/2159-8290.CD-20-1351. Epub 2021 Feb 10.

Current clinical RAF inhibitors (RAFi) inhibit monomeric BRAF (mBRAF) but are less potent against dimeric BRAF (dBRAF). RAFi equipotent for mBRAF and dBRAF have been developed but are predicted to have lower therapeutic index. Here we identify a third...

Cite
Adamopoulos C, Ahmed TA, Tucker MR, et al. Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer Discov. 2021;11(7):1716-1735doi: 10.1158/2159-8290.CD-20-1351.
Adamopoulos, C., Ahmed, T. A., Tucker, M. R., Ung, P. M. U., Xiao, M., Karoulia, Z., Amabile, A., Wu, X., Aaronson, S. A., Ang, C., Rebecca, V. W., Brown, B. D., Schlessinger, A., Herlyn, M., Wang, Q., Shaw, D. E., & Poulikakos, P. I. (2021). Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer discovery, 11(7), 1716-1735. https://doi.org/10.1158/2159-8290.CD-20-1351
Adamopoulos, Christos, et al. "Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling." Cancer discovery vol. 11,7 (2021): 1716-1735. doi: https://doi.org/10.1158/2159-8290.CD-20-1351
Adamopoulos C, Ahmed TA, Tucker MR, Ung PMU, Xiao M, Karoulia Z, Amabile A, Wu X, Aaronson SA, Ang C, Rebecca VW, Brown BD, Schlessinger A, Herlyn M, Wang Q, Shaw DE, Poulikakos PI. Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer Discov. 2021 Jul;11(7):1716-1735. doi: 10.1158/2159-8290.CD-20-1351. Epub 2021 Feb 10. PMID: 33568355; PMCID: PMC8295204.
Copy Download .nbib Format: NLM
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).

JMIR research protocols

Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Mom C, van Dorst EBL, Mourits MJE, Slangen BFM, Gaarenstroom KN, Zillikens MC, Leiner T, van der Kolk L, Collee M, Wevers M, Ausems MGEM, van Engelen K, Berger LP, van Asperen CJ, Gomez-Garcia EB, van de Beek I, Rookus MA, Hauptmann M, Bleiker EM, Schagen SB, Aaronson NK, Maas AHEM, van Leeuwen FE.
PMID: 33480862
JMIR Res Protoc. 2021 Jan 22;10(1):e24414. doi: 10.2196/24414.

BACKGROUND: BRCA1/2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) at 35 to 45 years of age. RRSO substantially decreases ovarian cancer risk, but at the cost of immediate menopause. Knowledge about the potential adverse effects of premenopausal...

Cite
Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, et al. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study). JMIR Res Protoc. 2021;10(1):e24414doi: 10.2196/24414.
Terra, L., Hooning, M. J., Heemskerk-Gerritsen, B. A. M., van Beurden, M., Roeters van Lennep, J. E., van Doorn, H. C., de Hullu, J. A., Mom, C., van Dorst, E. B. L., Mourits, M. J. E., Slangen, B. F. M., Gaarenstroom, K. N., Zillikens, M. C., Leiner, T., van der Kolk, L., Collee, M., Wevers, M., Ausems, M. G. E. M., van Engelen, K., Berger, L. P., van Asperen, C. J., Gomez-Garcia, E. B., van de Beek, I., Rookus, M. A., Hauptmann, M., Bleiker, E. M., Schagen, S. B., Aaronson, N. K., Maas, A. H. E. M., & van Leeuwen, F. E. (2021). Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study). JMIR research protocols, 10(1), e24414. https://doi.org/10.2196/24414
Terra, Lara, et al. "Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)." JMIR research protocols vol. 10,1 (2021): e24414. doi: https://doi.org/10.2196/24414
Terra L, Hooning MJ, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Mom C, van Dorst EBL, Mourits MJE, Slangen BFM, Gaarenstroom KN, Zillikens MC, Leiner T, van der Kolk L, Collee M, Wevers M, Ausems MGEM, van Engelen K, Berger LP, van Asperen CJ, Gomez-Garcia EB, van de Beek I, Rookus MA, Hauptmann M, Bleiker EM, Schagen SB, Aaronson NK, Maas AHEM, van Leeuwen FE. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study). JMIR Res Protoc. 2021 Jan 22;10(1):e24414. doi: 10.2196/24414. PMID: 33480862; PMCID: PMC7864779.
Copy Download .nbib Format: NLM
Impact of Blinding on Patient-Reported Outcome Differences between Treatment Arms in Cancer Randomized Controlled Trials.

Journal of the National Cancer Institute

Efficace F, Cella D, Aaronson NK, Calvert M, Cottone F, Di Maio M, Perrone F, Sparano F, Gamper EM, Vignetti M, Giesinger JM.
PMID: 34508610
J Natl Cancer Inst. 2021 Sep 11; doi: 10.1093/jnci/djab177. Epub 2021 Sep 11.

Some concerns have been raised about potential bias in patient-reported outcome (PRO) results from open-label cancer randomized controlled trials (RCTs). We investigated if open-label trials favor the experimental treatment over the standard treatment more frequently than blinded trials. We...

Cite
Efficace F, Cella D, Aaronson NK, et al. Impact of Blinding on Patient-Reported Outcome Differences between Treatment Arms in Cancer Randomized Controlled Trials. J Natl Cancer Inst. 2021;doi: 10.1093/jnci/djab177.
Efficace, F., Cella, D., Aaronson, N. K., Calvert, M., Cottone, F., Di Maio, M., Perrone, F., Sparano, F., Gamper, E. M., Vignetti, M., & Giesinger, J. M. (2021). Impact of Blinding on Patient-Reported Outcome Differences between Treatment Arms in Cancer Randomized Controlled Trials. Journal of the National Cancer Institute, . https://doi.org/10.1093/jnci/djab177
Efficace, Fabio, et al. "Impact of Blinding on Patient-Reported Outcome Differences between Treatment Arms in Cancer Randomized Controlled Trials." Journal of the National Cancer Institute vol. (2021). doi: https://doi.org/10.1093/jnci/djab177
Efficace F, Cella D, Aaronson NK, Calvert M, Cottone F, Di Maio M, Perrone F, Sparano F, Gamper EM, Vignetti M, Giesinger JM. Impact of Blinding on Patient-Reported Outcome Differences between Treatment Arms in Cancer Randomized Controlled Trials. J Natl Cancer Inst. 2021 Sep 11; doi: 10.1093/jnci/djab177. Epub 2021 Sep 11. PMID: 34508610.
Copy Download .nbib Format: NLM
Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic.

Journal of pain and symptom management

Aaronson EL, Daubman BR, Petrillo L, Bowman J, Ouchi K, Gips A, Traeger L, Jackson V, Grudzen C, Ritchie CS.
PMID: 33161031
J Pain Symptom Manage. 2021 Jul;62(1):117-124. doi: 10.1016/j.jpainsymman.2020.10.035. Epub 2020 Nov 06.

CONTEXT: Health systems have aspired to integrate palliative care (PC) into the emergency department (ED) to improve care quality for over a decade, yet there are very few examples of implemented models in the literature. The coronavirus disease 2019...

Cite
Aaronson EL, Daubman BR, Petrillo L, et al. Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic. J Pain Symptom Manage. 2020;62(1):117-124doi: 10.1016/j.jpainsymman.2020.10.035.
Aaronson, E. L., Daubman, B. R., Petrillo, L., Bowman, J., Ouchi, K., Gips, A., Traeger, L., Jackson, V., Grudzen, C., & Ritchie, C. S. (2021). Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic. Journal of pain and symptom management, 62(1), 117-124. https://doi.org/10.1016/j.jpainsymman.2020.10.035
Aaronson, Emily Loving, et al. "Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic." Journal of pain and symptom management vol. 62,1 (2021): 117-124. doi: https://doi.org/10.1016/j.jpainsymman.2020.10.035
Aaronson EL, Daubman BR, Petrillo L, Bowman J, Ouchi K, Gips A, Traeger L, Jackson V, Grudzen C, Ritchie CS. Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic. J Pain Symptom Manage. 2021 Jul;62(1):117-124. doi: 10.1016/j.jpainsymman.2020.10.035. Epub 2020 Nov 06. PMID: 33161031; PMCID: PMC7645272.
Copy Download .nbib Format: NLM
Past, present, and future of palliative care in emergency medicine in the USA.

Acute medicine & surgery

George N, Bowman J, Aaronson E, Ouchi K.
PMID: 32395248
Acute Med Surg. 2020 Mar 18;7(1):e497. doi: 10.1002/ams2.497. eCollection 2020.

The emergency department (ED) provides immediate access to medical care for patients and families in times of need. Increasingly, older patients with serious illness seek care in the ED, hoping for relief from symptoms and suffering associated with advanced...

Cite
George N, Bowman J, Aaronson E, et al. Past, present, and future of palliative care in emergency medicine in the USA. Acute Med Surg. 2020;7(1):e497doi: 10.1002/ams2.497.
George, N., Bowman, J., Aaronson, E., & Ouchi, K. (2020). Past, present, and future of palliative care in emergency medicine in the USA. Acute medicine & surgery, 7(1), e497. https://doi.org/10.1002/ams2.497
George, Naomi, et al. "Past, present, and future of palliative care in emergency medicine in the USA." Acute medicine & surgery vol. 7,1 (2020): e497. doi: https://doi.org/10.1002/ams2.497
George N, Bowman J, Aaronson E, Ouchi K. Past, present, and future of palliative care in emergency medicine in the USA. Acute Med Surg. 2020 Mar 18;7(1):e497. doi: 10.1002/ams2.497. eCollection 2020. PMID: 32395248; PMCID: PMC7204801.
Copy Download .nbib Format: NLM
Calling on the Patient's Perspective in Emergency Medicine: Analysis of 1 Year of a Patient Callback Program.

Journal of patient experience

Natsui S, Aaronson EL, Joseph TA, Goldsmith AJ, Sonis JD, Raja AS, White BA, Luciani-Mcgillivray I, Mort E.
PMID: 31853488
J Patient Exp. 2019 Dec;6(4):318-324. doi: 10.1177/2374373518805542. Epub 2018 Oct 17.

BACKGROUND: Patient-centered approaches in the evaluation of patient experience are increasingly important priorities for quality improvement in health-care delivery. Our objective was to investigate common themes in patient-reported data to better understand areas for improvement in the emergency department...

Cite
Natsui S, Aaronson EL, Joseph TA, et al. Calling on the Patient's Perspective in Emergency Medicine: Analysis of 1 Year of a Patient Callback Program. J Patient Exp. 2018;6(4):318-324doi: 10.1177/2374373518805542.
Natsui, S., Aaronson, E. L., Joseph, T. A., Goldsmith, A. J., Sonis, J. D., Raja, A. S., White, B. A., Luciani-Mcgillivray, I., & Mort, E. (2019). Calling on the Patient's Perspective in Emergency Medicine: Analysis of 1 Year of a Patient Callback Program. Journal of patient experience, 6(4), 318-324. https://doi.org/10.1177/2374373518805542
Natsui, Shaw, et al. "Calling on the Patient's Perspective in Emergency Medicine: Analysis of 1 Year of a Patient Callback Program." Journal of patient experience vol. 6,4 (2019): 318-324. doi: https://doi.org/10.1177/2374373518805542
Natsui S, Aaronson EL, Joseph TA, Goldsmith AJ, Sonis JD, Raja AS, White BA, Luciani-Mcgillivray I, Mort E. Calling on the Patient's Perspective in Emergency Medicine: Analysis of 1 Year of a Patient Callback Program. J Patient Exp. 2019 Dec;6(4):318-324. doi: 10.1177/2374373518805542. Epub 2018 Oct 17. PMID: 31853488; PMCID: PMC6908991.
Copy Download .nbib Format: NLM
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling.

Neuro-oncology advances

Coomans MB, Dirven L, Aaronson NK, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Sloan JA, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Taphoorn MJB.
PMID: 33409496
Neurooncol Adv. 2020 Oct 29;2(1):vdaa147. doi: 10.1093/noajnl/vdaa147. eCollection 2020.

BACKGROUND: Two methods combining survival and health-related quality of life (HRQoL) data in glioma trials to calculate the "net clinical benefit" were evaluated: Quality-adjusted effect sizes (QASES) and joint modeling (JM).METHODS: The net clinical benefit in two trials was...

Cite
Coomans MB, Dirven L, Aaronson NK, et al. Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Neurooncol Adv. 2020;2(1):vdaa147doi: 10.1093/noajnl/vdaa147.
Coomans, M. B., Dirven, L., Aaronson, N. K., Baumert, B. G., van den Bent, M., Bottomley, A., Brandes, A. A., Chinot, O., Coens, C., Gorlia, T., Herrlinger, U., Keime-Guibert, F., Malmström, A., Martinelli, F., Sloan, J. A., Stupp, R., Talacchi, A., Weller, M., Wick, W., Reijneveld, J. C., & Taphoorn, M. J. B. (2020). Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Neuro-oncology advances, 2(1), vdaa147. https://doi.org/10.1093/noajnl/vdaa147
Coomans, Marijke B, et al. "Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling." Neuro-oncology advances vol. 2,1 (2020): vdaa147. doi: https://doi.org/10.1093/noajnl/vdaa147
Coomans MB, Dirven L, Aaronson NK, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Sloan JA, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Taphoorn MJB. Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Neurooncol Adv. 2020 Oct 29;2(1):vdaa147. doi: 10.1093/noajnl/vdaa147. eCollection 2020. PMID: 33409496; PMCID: PMC7772555.
Copy Download .nbib Format: NLM
An early relook identifies high-risk trajectories in ambulatory advanced heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Kittleson MM, Ambardekar AV, Stevenson LW, Gilotra NA, Shah P, Ewald GA, Thibodeau JT, Stehlik J, Palardy M, Estep JD, Cascino TM, Baldwin JT, Jeffries N, Khalatbari S, Yosef M, Peters WT, Richards B, Mann DL, Aaronson KD, Stewart GC.
PMID: 34629234
J Heart Lung Transplant. 2021 Sep 16; doi: 10.1016/j.healun.2021.09.003. Epub 2021 Sep 16.

INTRODUCTION: Patients with ambulatory advanced heart failure (HF) are increasingly considered for durable mechanical circulatory support (MCS) and heart transplantation and their effective triage requires careful assessment of the clinical trajectory.METHODS: REVIVAL, a prospective, observational study, enrolled 400 ambulatory...

Cite
Kittleson MM, Ambardekar AV, Stevenson LW, et al. An early relook identifies high-risk trajectories in ambulatory advanced heart failure. J Heart Lung Transplant. 2021;doi: 10.1016/j.healun.2021.09.003.
Kittleson, M. M., Ambardekar, A. V., Stevenson, L. W., Gilotra, N. A., Shah, P., Ewald, G. A., Thibodeau, J. T., Stehlik, J., Palardy, M., Estep, J. D., Cascino, T. M., Baldwin, J. T., Jeffries, N., Khalatbari, S., Yosef, M., Peters, W. T., Richards, B., Mann, D. L., Aaronson, K. D., Stewart, G. C. (2021). An early relook identifies high-risk trajectories in ambulatory advanced heart failure. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, . https://doi.org/10.1016/j.healun.2021.09.003
Kittleson, Michelle M, et al. "An early relook identifies high-risk trajectories in ambulatory advanced heart failure." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. (2021). doi: https://doi.org/10.1016/j.healun.2021.09.003
Kittleson MM, Ambardekar AV, Stevenson LW, Gilotra NA, Shah P, Ewald GA, Thibodeau JT, Stehlik J, Palardy M, Estep JD, Cascino TM, Baldwin JT, Jeffries N, Khalatbari S, Yosef M, Peters WT, Richards B, Mann DL, Aaronson KD, Stewart GC. An early relook identifies high-risk trajectories in ambulatory advanced heart failure. J Heart Lung Transplant. 2021 Sep 16; doi: 10.1016/j.healun.2021.09.003. Epub 2021 Sep 16. PMID: 34629234.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 187 entries